We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNKD icon
1476
MannKind Corp
MNKD
$1.32B
– –
-5,710
Closed -$24K
MNOV icon
1477
MediciNova
MNOV
$66M
– –
-1,120
Closed -$4K
MRNA icon
1478
Moderna
MRNA
$23.6B
– –
-23,197
Closed -$8.93M
MRSN
1479
DELISTED
Mersana Therapeutics
MRSN
– –
-66
Closed -$15K
MSI icon
1480
Motorola Solutions
MSI
$77.4B
– –
-611
Closed -$141K
MTDR icon
1481
Matador Resources
MTDR
$6.09B
– –
-2,673
Closed -$101K
MYGN icon
1482
Myriad Genetics
MYGN
$312M
– –
-1,785
Closed -$57K
NFRA icon
1483
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.02B
– –
-2,026
Closed -$113K
NGNE icon
1484
Neurogene
NGNE
$712M
– –
-49
Closed -$7K
NKTR icon
1485
Nektar Therapeutics
NKTR
$2.58B
– –
-280
Closed -$75K
NKTX icon
1486
Nkarta
NKTX
$172M
– –
-755
Closed -$20K
NRIX icon
1487
Nurix Therapeutics
NRIX
$2.65B
– –
-1,015
Closed -$30K
NTLA icon
1488
Intellia Therapeutics
NTLA
$1.67B
– –
-1,680
Closed -$225K
NXTC icon
1489
NextCure
NXTC
$26.7M
– –
-53
Closed -$4K
OCUL icon
1490
Ocular Therapeutix
OCUL
$2.02B
– –
-1,750
Closed -$17K
OMER icon
1491
Omeros
OMER
$959M
– –
-1,430
Closed -$19K
ORIC icon
1492
Oric Pharmaceuticals
ORIC
$1.4B
– –
-900
Closed -$18K
OVID icon
1493
Ovid Therapeutics
OVID
$491M
– –
-1,555
Closed -$5K
OVV icon
1494
Ovintiv
OVV
$16.4B
– –
-22,572
Closed -$742K
PACB icon
1495
Pacific Biosciences
PACB
$368M
– –
-4,560
Closed -$116K
PAG icon
1496
Penske Automotive Group
PAG
$14.2B
– –
-14,527
Closed -$1.46M
PAHC icon
1497
Phibro Animal Health
PAHC
$1.39B
– –
-465
Closed -$10K
PASG icon
1498
Passage Bio
PASG
$14.1M
– –
-62
Closed -$12K
PBYI icon
1499
Puma Biotechnology
PBYI
$454M
– –
-930
Closed -$6K
PCRX icon
1500
Pacira BioSciences
PCRX
$997M
– –
-1,020
Closed -$57K
58 59
60
61 62

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.